AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 36088628 — intervention group
Group type: EXPERIMENTAL
Intervention: Denosumab (DMAb) long-term (>3 years; n=213)
Number of subjects: 752
Study 36088628 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n=327)
Number of subjects: 752
Study 36088628 — intervention group
Group type: EXPERIMENTAL
Intervention: Denosumab (DMAb) duration
Number of subjects: 752
Study 34694155 — intervention group
Group type: EXPERIMENTAL
Intervention: Full implementation support from a knowledge broker
Number of subjects: 18
Study 34694155 — intervention group
Group type: EXPERIMENTAL
Intervention: Partial implementation support from a knowledge broker
Number of subjects: 18
Study 35681097 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactoferrin 100 mg/day for 3 months
Number of subjects: 80
Study 35681097 — intervention group
Group type: COMPARATOR
Intervention: Ferrous sulfate 6 mg/kg/day for 3 months
Number of subjects: 80
Study 35681097 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of Lactoferrin vs Ferrous sulfate
Number of subjects: 80
Study 34117829 — intervention group
Group type: EXPERIMENTAL
Intervention: QLB‐III
Number of subjects: 80
Study 34117829 — intervention group
Group type: COMPARATOR
Intervention: QLB‐II
Number of subjects: 80
Study 34397455 — intervention group
Group type: EXPERIMENTAL
Intervention: High tie surgery
Number of subjects: 8287
Study 33736484 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital therapeutic mobile application
Number of subjects: 146
Study 33736484 — intervention group
Group type: COMPARATOR
Intervention: Standard weekly coaching sessions (Control)
Number of subjects: 146
Study 33736484 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital therapeutic mobile application (per-protocol)
Number of subjects: 146
Study 33736484 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment (Control)
Number of subjects: 146
Study 34196973 — intervention group
Group type: EXPERIMENTAL
Intervention: Robenacoxib (n=222)
Number of subjects: 449
Study 34196973 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n=227)
Number of subjects: 449
Study 34196973 — intervention group
Group type: EXPERIMENTAL
Intervention: Robenacoxib
Number of subjects: 449
Study 32434498 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-articular injection of autologous adipose tissue
Number of subjects: 0
Study 32434498 — intervention group
Group type: COMPARATOR
Intervention: Intra-articular injection of platelet-rich plasma (PRP)
Number of subjects: 0
Study 35025164 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture and moxibustion
Number of subjects: 0
Study 35025164 — intervention group
Group type: COMPARATOR
Intervention: Not specified
Number of subjects: 0
Study 33880752 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactiplantibacillus plantarum 299v (Lp299v, 1010 colony forming units), 4.2 mg iron, 12 mg ascorbic acid and 30 µg folic acid (Lp)
Number of subjects: 326
Study 33880752 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 326
Study 32836103 — intervention group
Group type: EXPERIMENTAL
Intervention: Excellent/very good health status
Number of subjects: 1116
Study 32836103 — intervention group
Group type: EXPERIMENTAL
Intervention: Good health status
Number of subjects: 1116
Study 32836103 — intervention group
Group type: EXPERIMENTAL
Intervention: Fair health status
Number of subjects: 1116
Study 32836103 — intervention group
Group type: EXPERIMENTAL
Intervention: Poor health status
Number of subjects: 1116
Study 36104105 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiotherapy-led breathing exercises for 6 weeks
Number of subjects: 40
Study 36104105 — intervention group
Group type: COMPARATOR
Intervention: Music therapy-led breathing exercises for 6 weeks
Number of subjects: 40
Study 34173669 — intervention group
Group type: EXPERIMENTAL
Intervention: General payments (GPs)
Number of subjects: 91
Study 34173669 — intervention group
Group type: EXPERIMENTAL
Intervention: Research funding (RF)
Number of subjects: 91
Study 34173669 — intervention group
Group type: EXPERIMENTAL
Intervention: RCTs involving any type of systemic therapy
Number of subjects: 91
Study 34173669 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical oncologist PIs
Number of subjects: 91
Study 34173669 — intervention group
Group type: EXPERIMENTAL
Intervention: Trials with phase III components
Number of subjects: 91
Study 34173669 — intervention group
Group type: EXPERIMENTAL
Intervention: RCTs involving radiotherapy
Number of subjects: 91
Study 34173669 — intervention group
Group type: EXPERIMENTAL
Intervention: PIs having accepted payment(s) from the manufacturer of the drug utilized in their RCT
Number of subjects: 91
Study 33363073 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-based family workshop intervention for 6 months
Number of subjects: 104
Study 33363073 — intervention group
Group type: COMPARATOR
Intervention: Routine parenting guidance
Number of subjects: 104
Study 32101663 — intervention group
Group type: EXPERIMENTAL
Intervention: Pembrolizumab plus neoadjuvant chemotherapy (200 mg every 3 weeks)
Number of subjects: 1174
Study 32101663 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus neoadjuvant chemotherapy
Number of subjects: 1174
Study 32101663 — intervention group
Group type: EXPERIMENTAL
Intervention: Pembrolizumab plus neoadjuvant chemotherapy
Number of subjects: 1174
Study 34470186 — intervention group
Group type: EXPERIMENTAL
Intervention: MNT administered monthly (Group A)
Number of subjects: 98
Study 34470186 — intervention group
Group type: EXPERIMENTAL
Intervention: MNT administered every 3 months (Group B)
Number of subjects: 98
Study 34470186 — intervention group
Group type: COMPARATOR
Intervention: No access to nutritional therapy (Group C)
Number of subjects: 98
Study 32315396 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive geriatric assessment (CGA) conducted in the emergency department (ED)
Number of subjects: 0
Study 32315396 — intervention group
Group type: COMPARATOR
Intervention: Comprehensive geriatric assessment (CGA)
Number of subjects: 0
Study 36237734 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-Component Psychological Intervention
Number of subjects: 24
Study 36237734 — intervention group
Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 24
Study 32816842 — intervention group
Group type: EXPERIMENTAL
Intervention: TARGIT‐IORT
Number of subjects: 2298
Study 32816842 — intervention group
Group type: COMPARATOR
Intervention: EBRT
Number of subjects: 2298
Study 36282220 — intervention group
Group type: COMPARATOR
Intervention: Erector spinae plane block (ESPB) with 20 mL 0.375% bupivacaine
Number of subjects: 83
Study 36282220 — intervention group
Group type: EXPERIMENTAL
Intervention: Thoracal paravertebral block (TPVB) with 20 mL 0.375% bupivacaine
Number of subjects: 83
Study 35528962 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored intervention package including in-person education about TB management, bimonthly electronic refreshers, context-specific selection of referral pathways, and access to a TB-reporting app.
Number of subjects: 36
Study 35528962 — intervention group
Group type: COMPARATOR
Intervention: Control group receiving standard care without the tailored intervention package.
Number of subjects: 36
Study 32063222 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral stress management
Number of subjects: 100
Study 32063222 — intervention group
Group type: COMPARATOR
Intervention: Routine prenatal examination and health education
Number of subjects: 100
Study 35304614 — intervention group
Group type: EXPERIMENTAL
Intervention: Genicular artery embolization using imipenem/cilastatin
Number of subjects: 0
Study 35304614 — intervention group
Group type: COMPARATOR
Intervention: Genicular artery embolization using microspheres
Number of subjects: 0
Study 35304614 — intervention group
Group type: EXPERIMENTAL
Intervention: Genicular artery embolization (both interventions)
Number of subjects: 0
Study 36166781 — intervention group
Group type: EXPERIMENTAL
Intervention: Video visits
Number of subjects: 135
Study 36166781 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote testing
Number of subjects: 135
Study 36166781 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual second opinions
Number of subjects: 135
Study 36166781 — intervention group
Group type: EXPERIMENTAL
Intervention: eConsults
Number of subjects: 135
Study 34365952 — intervention group
Group type: EXPERIMENTAL
Intervention: Proximal tibial anatomical axis measurement
Number of subjects: 200
Study 34365952 — intervention group
Group type: COMPARATOR
Intervention: Whole tibial anatomical axis measurement
Number of subjects: 200
Study 34173298 — intervention group
Group type: EXPERIMENTAL
Intervention: Alpelisib plus fulvestrant
Number of subjects: 0
Study 34173298 — intervention group
Group type: COMPARATOR
Intervention: Control not specified
Number of subjects: 0
Study 33066603 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition literacy
Number of subjects: 218
Study 33066603 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary adherence rate
Number of subjects: 218
Study 33066603 — intervention group
Group type: EXPERIMENTAL
Intervention: Limited nutrition literacy
Number of subjects: 218
Study 32127868 — intervention group
Group type: EXPERIMENTAL
Intervention: Insomnia
Number of subjects: 436
Study 32127868 — intervention group
Group type: EXPERIMENTAL
Intervention: Change in sleep habits
Number of subjects: 436
Study 32127868 — intervention group
Group type: EXPERIMENTAL
Intervention: Not waking up feeling rested
Number of subjects: 436
Study 32127868 — intervention group
Group type: EXPERIMENTAL
Intervention: Decrease in sleep
Number of subjects: 436
Study 32127868 — intervention group
Group type: EXPERIMENTAL
Intervention: Increase in sleep
Number of subjects: 436
Study 35957925 — intervention group
Group type: EXPERIMENTAL
Intervention: Coronary artery disease (CAD)
Number of subjects: 145
Study 35957925 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower educational status
Number of subjects: 145
Study 35957925 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher P-selectin levels
Number of subjects: 145
Study 35957925 — intervention group
Group type: EXPERIMENTAL
Intervention: Age > 65 years
Number of subjects: 145
Study 35957925 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-Minute Walk Test < 432 m
Number of subjects: 145
Study 35957925 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum glucose > 120 mg/dL
Number of subjects: 145
Study 35957925 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum cortisol > 10 μg/dL
Number of subjects: 145
Study 35957925 — intervention group
Group type: EXPERIMENTAL
Intervention: Leptin ≥ 15 ng/mL
Number of subjects: 145
Study 35957925 — intervention group
Group type: EXPERIMENTAL
Intervention: GDNF ≥ 20 pg/mL
Number of subjects: 145
Study 33632160 — intervention group
Group type: EXPERIMENTAL
Intervention: Online haemodiafiltration (HDF)
Number of subjects: 1620
Study 33632160 — intervention group
Group type: COMPARATOR
Intervention: Haemodialysis (HD)
Number of subjects: 1620
Study 33203365 — intervention group
Group type: EXPERIMENTAL
Intervention: Collaborative care (CC) for depression
Number of subjects: 731
Study 33203365 — intervention group
Group type: EXPERIMENTAL
Intervention: Collaborative care (CC) for anxiety
Number of subjects: 731
Study 33203365 — intervention group
Group type: COMPARATOR
Intervention: Treatment-as-usual (control group)
Number of subjects: 731
Study 33840474 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxygen delivery strategy (maintaining an oxygen delivery index value >300 mL/min/m2 through pump flow adjustments)
Number of subjects: 300
Study 33840474 — intervention group
Group type: COMPARATOR
Intervention: Conventional strategy (target pump flow based on body surface area)
Number of subjects: 300
Study 32861603 — intervention group
Group type: EXPERIMENTAL
Intervention: Taurine 3,000 mg/day for 8 weeks
Number of subjects: 46
Study 32273749 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention in pain management for nursing staff, including classroom (quality circles) and web-based training.
Number of subjects: 569
Study 32273749 — intervention group
Group type: COMPARATOR
Intervention: Control group (no educational intervention).
Number of subjects: 569
Study 32273749 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention in pain management for nursing staff.
Number of subjects: 569
Study 33161276 — intervention group
Group type: EXPERIMENTAL
Intervention: Generation 2 posture bra
Number of subjects: 24
Study 33161276 — intervention group
Group type: COMPARATOR
Intervention: Everyday bra
Number of subjects: 24
Study 33161276 — intervention group
Group type: COMPARATOR
Intervention: No bra
Number of subjects: 24
Study 32736338 — intervention group
Group type: EXPERIMENTAL
Intervention: NMES 80% BFR
Number of subjects: 20
Study 32736338 — intervention group
Group type: COMPARATOR
Intervention: NMES 40% BFR
Number of subjects: 20
Study 32736338 — intervention group
Group type: COMPARATOR
Intervention: NMES 60% BFR
Number of subjects: 20
Study 32736338 — intervention group
Group type: COMPARATOR
Intervention: NMES alone
Number of subjects: 20
Study 34748214 — intervention group
Group type: EXPERIMENTAL
Intervention: Conversational agent (dialogic reading)
Number of subjects: 117
Study 34748214 — intervention group
Group type: COMPARATOR
Intervention: Adult reading partner (non-dialogic reading)
Number of subjects: 117
Study 34563585 — intervention group
Group type: EXPERIMENTAL
Intervention: Luseogliflozin 2.5 mg/day
Number of subjects: 56
Study 34563585 — intervention group
Group type: COMPARATOR
Intervention: DPP-4 inhibitor
Number of subjects: 56
Study 33141657 — intervention group
Group type: EXPERIMENTAL
Intervention: Annual mammography screening (film mammography, two views at first screen and single view thereafter)
Number of subjects: 160836
Study 33141657 — intervention group
Group type: EXPERIMENTAL
Intervention: Annual mammography screening
Number of subjects: 160836
Study 33141657 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 160836
Study 35102226 — intervention group
Group type: EXPERIMENTAL
Intervention: Desogestrel (DSG 150 µg/d, n=50)
Number of subjects: 104
Study 35102226 — intervention group
Group type: COMPARATOR
Intervention: Medroxyprogesterone acetate (MPA 10 mg/d, n=54)
Number of subjects: 104
Study 35102226 — intervention group
Group type: EXPERIMENTAL
Intervention: Desogestrel (DSG)
Number of subjects: 104
Study 35102226 — intervention group
Group type: COMPARATOR
Intervention: Medroxyprogesterone acetate (MPA)
Number of subjects: 104
Study 33246344 — intervention group
Group type: EXPERIMENTAL
Intervention: Logistic regression model using 949 variates
Number of subjects: 261758
Study 33246344 — intervention group
Group type: EXPERIMENTAL
Intervention: Logistic regression model using 72 variates
Number of subjects: 261758
Study 33246344 — intervention group
Group type: EXPERIMENTAL
Intervention: Logistic regression model
Number of subjects: 261758
Study 32346706 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous curvilinear buccal‐cervical incision
Number of subjects: 87
Study 32346706 — intervention group
Group type: COMPARATOR
Intervention: Conventional cervical T shaped incision combined with a buccal incision
Number of subjects: 87
Study 36293928 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrotherapy group (46 subjects)
Number of subjects: 90
Study 36293928 — intervention group
Group type: COMPARATOR
Intervention: Sham electrotherapy group (44 subjects)
Number of subjects: 90
Study 36293928 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison between groups
Number of subjects: 90
Study 34528981 — intervention group
Group type: EXPERIMENTAL
Intervention: LGG fermented milk (150 mL containing 108 CFU mL‐1 LGG)
Number of subjects: 20
Study 34528981 — intervention group
Group type: COMPARATOR
Intervention: Lactic-acidified milk (placebo)
Number of subjects: 20
Study 33992259 — intervention group
Group type: EXPERIMENTAL
Intervention: CT + NM
Number of subjects: 66
Study 33992259 — intervention group
Group type: COMPARATOR
Intervention: CT + sham NM
Number of subjects: 66
Study 33992259 — intervention group
Group type: COMPARATOR
Intervention: WLC
Number of subjects: 66
Study 35988204 — intervention group
Group type: EXPERIMENTAL
Intervention: BC‐He novel nano bio‐vascular stent
Number of subjects: 98
Study 35988204 — intervention group
Group type: COMPARATOR
Intervention: Conventional nursing (group A)
Number of subjects: 98
Study 35988204 — intervention group
Group type: EXPERIMENTAL
Intervention: Perioperative nursing (group B)
Number of subjects: 98
Study 33978711 — intervention group
Group type: EXPERIMENTAL
Intervention: Baricitinib 4 mg
Number of subjects: 124
Study 33978711 — intervention group
Group type: EXPERIMENTAL
Intervention: Baricitinib 2 mg
Number of subjects: 124
Study 33034565 — intervention group
Group type: EXPERIMENTAL
Intervention: Technology-enabled self-monitoring program
Number of subjects: 18
Study 33034565 — intervention group
Group type: EXPERIMENTAL
Intervention: Technology-enabled self- and remote-monitoring program
Number of subjects: 18
Study 33034565 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 18
Study 35822565 — intervention group
Group type: EXPERIMENTAL
Intervention: sacubitril/valsartan
Number of subjects: 371
Study 35822565 — intervention group
Group type: COMPARATOR
Intervention: valsartan
Number of subjects: 371
Study 35822565 — intervention group
Group type: EXPERIMENTAL
Intervention: medication withdrawal
Number of subjects: 371
Study 35822565 — intervention group
Group type: COMPARATOR
Intervention: maintenance group
Number of subjects: 371
Study 35822565 — intervention group
Group type: EXPERIMENTAL
Intervention: not specified
Number of subjects: 371
Study 34234539 — intervention group
Group type: EXPERIMENTAL
Intervention: active cTBS
Number of subjects: 28
Study 34234539 — intervention group
Group type: COMPARATOR
Intervention: sham cTBS
Number of subjects: 28
Study 35881121 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose tranexamic acid (30 mg/kg bolus, 16 mg/kg/h maintenance, 2 mg/kg prime)
Number of subjects: 3079
Study 35881121 — intervention group
Group type: COMPARATOR
Intervention: Low-dose tranexamic acid (10 mg/kg bolus, 2 mg/kg/h maintenance, 1 mg/kg prime)
Number of subjects: 3079
Study 35881121 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose tranexamic acid
Number of subjects: 3079
Study 35881121 — intervention group
Group type: COMPARATOR
Intervention: Low-dose tranexamic acid
Number of subjects: 3079
Study 32279172 — intervention group
Group type: EXPERIMENTAL
Intervention: Fecal Microbiota Transplantation (FMT)
Number of subjects: 29
Study 32279172 — intervention group
Group type: COMPARATOR
Intervention: Antiviral therapy (AVT)
Number of subjects: 29
Study 36183506 — intervention group
Group type: EXPERIMENTAL
Intervention: Fractional Radiofrequency (FRF)
Number of subjects: 30
Study 36183506 — intervention group
Group type: EXPERIMENTAL
Intervention: Microneedling
Number of subjects: 30
Study 33748833 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose influenza vaccine
Number of subjects: 5200
Study 33748833 — intervention group
Group type: COMPARATOR
Intervention: Standard-dose influenza vaccine
Number of subjects: 5200
Study 35324989 — intervention group
Group type: EXPERIMENTAL
Intervention: 140 Hz transcranial alternating current stimulation (tACS) at 1.0 mA
Number of subjects: 17
Study 35324989 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 17
Study 35324989 — intervention group
Group type: EXPERIMENTAL
Intervention: 140 Hz transcranial alternating current stimulation (tACS)
Number of subjects: 17
Study 33717093 — intervention group
Group type: EXPERIMENTAL
Intervention: Icaritin
Number of subjects: 0
Study 32589056 — intervention group
Group type: EXPERIMENTAL
Intervention: Early intervention arm (educational information mailed to patients and their providers)
Number of subjects: 80000
Study 32589056 — intervention group
Group type: COMPARATOR
Intervention: Delayed intervention arm (educational information mailed to providers of patients approximately 12 months later)
Number of subjects: 80000
Study 35610712 — intervention group
Group type: EXPERIMENTAL
Intervention: CHW-led intervention (monthly household visits for 1 year)
Number of subjects: 869
Study 34051389 — intervention group
Group type: EXPERIMENTAL
Intervention: One dose of HPV vaccine
Number of subjects: 37
Study 34051389 — intervention group
Group type: EXPERIMENTAL
Intervention: Two doses of HPV vaccine
Number of subjects: 37
Study 34051389 — intervention group
Group type: EXPERIMENTAL
Intervention: Three doses of HPV vaccine
Number of subjects: 37
Study 34159751 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed-dose combination of amlodipine 5 mg, losartan 100 mg, and chlorthalidone 25 mg
Number of subjects: 60
Study 34159751 — intervention group
Group type: COMPARATOR
Intervention: Separate components (loose combination) of amlodipine/losartan 5/100 mg and chlorthalidone 25 mg
Number of subjects: 60
Study 33910578 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) triple therapy
Number of subjects: 8094
Study 33910578 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibrinogen levels ≥ 3.5 g/L
Number of subjects: 8094
Study 33910578 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibrinogen quartiles
Number of subjects: 8094
Study 33910578 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiovascular adverse events of special interest (AESIs)
Number of subjects: 8094
Study 33369660 — intervention group
Group type: EXPERIMENTAL
Intervention: IVR training platform for reverse shoulder arthroplasty; participants could repeat the module indefinitely.
Number of subjects: 18
Study 35296402 — intervention group
Group type: EXPERIMENTAL
Intervention: Alirocumab
Number of subjects: 18262
Study 35296402 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18262
Study 35296402 — intervention group
Group type: EXPERIMENTAL
Intervention: History of atrial fibrillation
Number of subjects: 18262
Study 35296402 — intervention group
Group type: COMPARATOR
Intervention: Randomized treatment (Alirocumab vs Placebo)
Number of subjects: 18262
Study 32970367 — intervention group
Group type: EXPERIMENTAL
Intervention: Basic psychological need-satisfying activities intervention (n = 98)
Number of subjects: 208
Study 32970367 — intervention group
Group type: COMPARATOR
Intervention: Control (neutral comparison group, n = 110)
Number of subjects: 208
Study 35468864 — intervention group
Group type: EXPERIMENTAL
Intervention: Tai Chi combined with Kinesio taping
Number of subjects: 0
Study 35468864 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 32139381 — intervention group
Group type: EXPERIMENTAL
Intervention: Liraglutide 3.0 mg
Number of subjects: 396
Study 32139381 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 396
Study 36480510 — intervention group
Group type: EXPERIMENTAL
Intervention: Active tDCS (20 minutes at 2 mA) for 10 daily sessions plus 5 follow up sessions
Number of subjects: 50